Clinical trial
Heritability of Polycystic Ovary Syndrome: Role of Antimullerian Hormone, Steroids and Leptin
NCT03483792 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Heritability of Polycystic Ovary Syndrome: Role of Antimullerian Hormone, Steroids and Leptin
- Lead sponsor
- University Hospital, Lille
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 20, 2018
- Completion date
- June 2, 2022
- Enrollment
- 58 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.